News

BTS said that customers thus now benefit from Asian network that is managed from the BTS regional headquarters in Shanghai. The new Southeast Asia office will be headed

Shire said that Vpriv offers patients and their physicians a new treatment option at a critical time, as the supply of the previously approved ERT for gaucher disease

Thermo Fisher Scientific said that the ultra-low bleed TraceGOLD GC columns ensure high sensitivity levels are obtained with low baseline noise, resulting in improved limits of detection with

While there was a consistent trend in favor of Bosentan, the primary endpoint, reduction in morbidity/mortality, was not met (p=0.21). The well characterised safety profile of Bosentan was

Astellas’ latest offer to buy out OSI at a 50% premium on February 12, 2010 was rejected by OSI as ”too low’. Astellas said that it will now

Reportedly, in May 2009, Almac Group was officially accredited for cGMP manufacturing and received investigational medicinal products (IMP) drug product-manufacturing license from the Medicines and Healthcare Regulatory Agency

In the randomised stroke prevention trials, the Carotid Revascularisation Endarterectomy vs Stenting Trial (CREST) took place at 117 centers in the US and Canada over a nine-year period.

Cobroxin is the over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3,

Ipsen has posted a net income of EUR157.16m, an increase of 6.9%, compared to EUR147.07m. Total revenues were EUR1.11bn, an increase of 7.2%, compared to EUR1.04bn for the